Chitra Mandal Selected Research

Drug-Related Side Effects and Adverse Reactions

4/2018

Porphyrin-Gold Nanomaterial for Efficient Drug Delivery to Cancerous Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chitra Mandal Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 10/2006
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015 - 05/2004
12	Visceral Leishmaniasis (Kala Azar) 01/2021 - 05/2003
10	Infections 01/2021 - 09/2007
7	Hemolysis 01/2012 - 04/2004
4	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2018
4	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 02/2013
4	Carcinogenesis 01/2019 - 10/2010
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2014
4	Leukemia 02/2014 - 10/2004
4	Anemia 01/2011 - 04/2004
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2014
3	Leishmaniasis 01/2021 - 01/2007
3	Adenocarcinoma 12/2018 - 02/2014
3	Neoplasm Metastasis (Metastasis) 04/2018 - 01/2017
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2009 - 02/2008
2	Disease Progression 01/2021 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 08/2014
2	Brain Neoplasms (Brain Tumor) 04/2018 - 01/2017
2	Residual Neoplasm 10/2014 - 10/2007
2	Melanoma (Melanoma, Malignant) 01/2009 - 10/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Pseudomonas Infections 01/2020
1	Drug-Related Side Effects and Adverse Reactions 04/2018
1	Hypersensitivity (Allergy) 01/2017
1	Ascites 02/2016
1	Colonic Neoplasms (Colon Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

8	mahanineIBA 02/2024 - 02/2013
8	Sialic AcidsIBA 01/2021 - 02/2006
6	AntibodiesIBA 04/2010 - 05/2004
5	AlkaloidsIBA 01/2020 - 02/2013
5	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020 - 05/2003
5	carbazoleIBA 01/2020 - 02/2013
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2009
5	EnzymesIBA 02/2016 - 09/2004
5	SialoglycoproteinsIBA 01/2012 - 10/2004
5	achatinin(H)IBA 06/2009 - 04/2004
4	CytokinesIBA 01/2021 - 01/2016
4	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2021 - 01/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2007
4	Complement System Proteins (Complement)IBA 12/2009 - 04/2004
3	Neuraminidase (Sialidase)IBA 03/2022 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2010
3	PhosphatidylserinesIBA 01/2012 - 10/2006
3	C-Reactive ProteinIBA 12/2009 - 05/2006
2	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 01/2014
2	CalciumIBA 01/2020 - 01/2012
2	SialyltransferasesIBA 12/2018 - 04/2010
2	Messenger RNA (mRNA)IBA 01/2017 - 04/2010
2	Pyruvaldehyde (Methylglyoxal)IBA 01/2015 - 06/2009
2	AcetyltransferasesIBA 01/2012 - 01/2009
2	SpectrinIBA 01/2012 - 01/2011
2	LigandsIBA 01/2012 - 04/2009
2	ArsenicIBA 10/2010 - 01/2009
2	CeramidesIBA 09/2010 - 10/2006
2	p38 Mitogen-Activated Protein KinasesIBA 09/2010 - 06/2009
2	ImmunosorbentsIBA 05/2006 - 09/2004
1	Cell Cycle ProteinsIBA 01/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	koenimbinIBA 01/2020
1	mahanimbineIBA 01/2020
1	ethyl acetateIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	epidermal growth factor receptor VIIIIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 04/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2018
1	SaltsIBA 04/2018
1	tetraphenylporphine sulfonate (TPPS)IBA 04/2018
1	meso- tetrakis(4- sulfonatophenyl)porphyrinIBA 04/2018
1	GoldIBA 04/2018
1	Beclin-1IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	ArginaseIBA 01/2017
1	Cyclin EIBA 01/2017
1	Cyclin D2IBA 01/2017
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 02/2016
1	Pyruvate KinaseIBA 02/2016
1	MethylcholanthreneIBA 02/2016
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	CholesterolIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	GangliosidesIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	Asparaginase (Elspar)FDA Link 02/2014
1	CateninsIBA 02/2014

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2012 - 05/2004
3	Therapeutics 01/2019 - 01/2008
2	Transplantation 10/2014 - 10/2007
1	Immunotherapy 10/2014